¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀå´ë»çÁõÈıºÇÐȸ 2023 Ãß°è½ÉÆ÷Áö¾ö : 2023-09-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

½ÉÀå´ë»çÁõÈıºÇÐȸ 2023 Ãß°è½ÉÆ÷Áö¾ö : 2023-09-23
±³À°ÀÏÀÚ : 2023-09-23
±³À°Àå¼Ò : Swiss Grand Seoul (Flamingo room)

±³À°ÁÖÁ¦ : ½ÉÀå´ë»çÁõÈıºÇÐȸ 2023 Ãß°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ

´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 010-9222-8977

À̸ÞÀÏ : apcms@kscms.org

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í "»çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ – 4¸¸¿ø, ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ – ¹«·á

ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ - 5¸¸¿ø, ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ – ¹«·á"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 09:00~09:20 GLP-1 with weight loss and belly fat loss ¼­¹ÌÇý(¼øõÇâÀÇ´ë ±¸¹Ìº´¿ø ³»ºÐºñ³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 09:20~09:40 GLP-1 and ASCVD Reduction Indications À¯ÁöÈñ(¿¬¼¼¿øÁÖÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 09:40~10:00 Cases of Basal Insulin and GLP-1 ±èÇ强(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 09¿ù 23ÀÏ Flamingo room 10:00~10:20 Discussion ±è¼ºÈ¯, ¹®¼±ÁØ, Á¤¹ÌÇâ, ±è°æ¹Î(°í·ÁÀÇ´ë, ¼º±Õ°üÀÇ´ë, °¡Å縯ÀÇ´ë, ¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 10:50~11:10 Mind-Body Intervention for stress reduction and Cardiometabolic Health À念¿ì(°¡ÃµÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 11:10~11:30 Appropriate exercise education for the elderly and frail population ±è¹ÌÁö(°æÈñ´ë ÀϹݴëÇпø À¶ÇÕÀÇ°úÇаú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 11:30~11:50 Diet and Cardiometabolic health : Lp(a) revisited ½Å¹ÎÁ¤(°í·Á´ë ¹ÙÀÌ¿À½Ã½ºÅÛÀÇ°úÇкÎ)

Åä·Ð 09¿ù 23ÀÏ Flamingo room 11:50~12:10 Discussion ¹Ú°æ, ¹Ú»ó¹Î, ¼­Àçºó, À̹ÎÈ£(¿µ³²´ëÇб³, À»ÁöÀÇ´ë, ¼­¿ïÀÇ´ë, ¼øõÇâÀÇ´ë)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 12:10~12:25 Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy ¼­¿ø¿ì(ÇѸ²ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 12:25~12:40 Prevention of CVD in hypertension with diabetes ±èÇöÁø(ÇѾçÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 13:30~13:50 Understanding TG metabolism and its Relationship with Cardiovascular Risk ±è³²ÈÆ(°í·ÁÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 13:50~14:10 Evidence-based Overview for TG Lowering Therapy ±èÇзÉ(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 14:10~14:30 Integrating TG lowering Strategies into ASCVD Prevention Á¶»óÈ£(ÇѸ²ÀÇ´ë ¼øȯ±â³»°ú)

Åä·Ð 09¿ù 23ÀÏ Flamingo room 14:30~14:50 Discussion ¹Î¼¼Èñ, °­º´±Ô, Á¤ÀçÈÆ, °ø¹Î±Ô(¿ï»êÀÇ´ë, ÀÎÁ¦ÀÇ´ë, ±¹¸³Áß¾ÓÀÇ·á¿ø, ¼øõÇâÀÇ´ë)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 14:50~15:10 GLP1-receptor agonists are better ÀÓ¼ö(¼­¿ïÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 15:10~15:30 SGLT2 inhibitors are better ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë ¼øȯ±â³»°ú)

Åä·Ð 09¿ù 23ÀÏ Flamingo room 15:30~15:50 Discussion È«¼øÁØ, ÃÖÈ¿ÀÎ, À̽ÃÈÆ, È«ÁØÈ­(°í·ÁÀÇ´ë, ¼º±Õ°üÀÇ´ë, °¡ÃµÀÇ´ë, À»ÁöÀÇ´ë)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 16:10~16:30 Tackling the Dual Epidemics of Diabetes and Obesity: Insights from Clinical Trials (SURMOUNT2 and OASIS -PIONEER PLUS) ¹Ú¼¼Àº(¼º±Õ°üÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 16:30~16:50 Advancements in Cardiometabolic Disease Management: Highlights from LBTs (PRECISION and BrigHTN) ¾ÈÈ¿¼®(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 09¿ù 23ÀÏ Flamingo room 16:50~17:10 Beyond Statins: Emerging Strategies for Managing Dyslipidemia (CLEAR-OUTCOMES and OCEAN(a)-DOSE) À§Áø(°¡ÃµÀÇ´ë ½ÉÀå³»°ú)

Åä·Ð 09¿ù 23ÀÏ Flamingo room 17:10~17:30 Discussion À¯½Â±â, ¹ÚÈÆÁØ, ¹®Á¤±Ù, ¹Ú¼ÒÈñ(ÀÌÈ­ÀÇ´ë, °¡Å縯ÀÇ´ë, °¡ÃµÀÇ´ë, ÀÎÁ¦ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀå´ë»çÁõÈıºÇÐȸ 2023 Ãß°è½ÉÆ÷Áö¾ö : 2023-09-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ The 4th Seoul Aorta Symposium : 2023-09-23
´ÙÀ½±Û 2023³âµµ Á¦6ȸ ±âħ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2023-09-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 73 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 54 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 44 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 45 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷